Market Research Logo

Digna Biotech, S.L. - Product Pipeline Review - 2016

Digna Biotech, S.L. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Digna Biotech, S.L. - Product Pipeline Review - 2016’, provides an overview of the Digna Biotech, S.L.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Digna Biotech, S.L., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Digna Biotech, S.L.
The report provides overview of Digna Biotech, S.L. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Digna Biotech, S.L.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Digna Biotech, S.L.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Digna Biotech, S.L.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Digna Biotech, S.L.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Digna Biotech, S.L.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Digna Biotech, S.L. Snapshot
Digna Biotech, S.L. Overview
Key Information
Key Facts
Digna Biotech, S.L. - Research and Development Overview
Key Therapeutic Areas
Digna Biotech, S.L. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Digna Biotech, S.L. - Pipeline Products Glance
Digna Biotech, S.L. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Digna Biotech, S.L. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Digna Biotech, S.L. - Drug Profiles
Cardiotrophin-1
Product Description
Mechanism of Action
R&D Progress
disitertide
Product Description
Mechanism of Action
R&D Progress
Interferon Alfa-5
Product Description
Mechanism of Action
R&D Progress
DB-017
Product Description
Mechanism of Action
R&D Progress
DB-02901
Product Description
Mechanism of Action
R&D Progress
DB-036
Product Description
Mechanism of Action
R&D Progress
DB-039
Product Description
Mechanism of Action
R&D Progress
DB-055
Product Description
Mechanism of Action
R&D Progress
oncostatin M
Product Description
Mechanism of Action
R&D Progress
DB-027
Product Description
Mechanism of Action
R&D Progress
Digna Biotech, S.L. - Pipeline Analysis
Digna Biotech, S.L. - Pipeline Products by Target
Digna Biotech, S.L. - Pipeline Products by Route of Administration
Digna Biotech, S.L. - Pipeline Products by Molecule Type
Digna Biotech, S.L. - Pipeline Products by Mechanism of Action
Digna Biotech, S.L. - Recent Pipeline Updates
Digna Biotech, S.L. - Dormant Projects
Digna Biotech, S.L. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Digna Biotech, S.L., Key Information
Digna Biotech, S.L., Key Facts
Digna Biotech, S.L. - Pipeline by Indication, 2016
Digna Biotech, S.L. - Pipeline by Stage of Development, 2016
Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016
Digna Biotech, S.L. - Partnered Products in Pipeline, 2016
Digna Biotech, S.L. - Partnered Products/ Combination Treatment Modalities, 2016
Digna Biotech, S.L. - Phase II, 2016
Digna Biotech, S.L. - Phase I, 2016
Digna Biotech, S.L. - Preclinical, 2016
Digna Biotech, S.L. - Discovery, 2016
Digna Biotech, S.L. - Pipeline by Target, 2016
Digna Biotech, S.L. - Pipeline by Route of Administration, 2016
Digna Biotech, S.L. - Pipeline by Molecule Type, 2016
Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016
Digna Biotech, S.L. - Recent Pipeline Updates, 2016
Digna Biotech, S.L. - Dormant Developmental Projects,2016
Digna Biotech, S.L., Other Locations
Digna Biotech, S.L., Subsidiaries
List of Figures
Digna Biotech, S.L. - Pipeline by Top 10 Indication, 2016
Digna Biotech, S.L. - Pipeline by Stage of Development, 2016
Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016
Digna Biotech, S.L. - Pipeline by Target, 2016
Digna Biotech, S.L. - Pipeline by Route of Administration, 2016
Digna Biotech, S.L. - Pipeline by Molecule Type, 2016
Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report